Comparison of the therapeutic dose of warfarin in HIV-infected and HIV-uninfected patients: a study of clinical practice

BACKGROUND: People infected with HIV are prone to venous thrombosis. Treatment of thrombosis is primarily with warfarin. No studies have addressed the effects of HIV infection on warfarin dose. The aims of this study were to determine whether the therapeutic dose of warfarin and induction time to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, B S, Mokoena, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306524/
https://www.ncbi.nlm.nih.gov/pubmed/28179414
http://dx.doi.org/10.1136/bmjopen-2016-013709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306524/
https://www.ncbi.nlm.nih.gov/pubmed/28179414
http://dx.doi.org/10.1136/bmjopen-2016-013709

Ejemplares similares